
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
Market Analysis and Insights: Global Rheumatoid Arthritis Testing Market
The global Rheumatoid Arthritis Testing market is projected to grow from US$ 2318.3 million in 2024 to US$ 3487 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Covers:
This report presents an overview of global market for Rheumatoid Arthritis Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rheumatoid Arthritis Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rheumatoid Arthritis Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rheumatoid Arthritis Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Rheumatoid Arthritis Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Rheumatoid Arthritis Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rheumatoid Arthritis Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Serological Tests
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.2.4 Imaging Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Testing Market Perspective (2019-2030)
2.2 Global Rheumatoid Arthritis Testing Growth Trends by Region
2.2.1 Rheumatoid Arthritis Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rheumatoid Arthritis Testing Historic Market Size by Region (2019-2024)
2.2.3 Rheumatoid Arthritis Testing Forecasted Market Size by Region (2025-2030)
2.3 Rheumatoid Arthritis Testing Market Dynamics
2.3.1 Rheumatoid Arthritis Testing Industry Trends
2.3.2 Rheumatoid Arthritis Testing Market Drivers
2.3.3 Rheumatoid Arthritis Testing Market Challenges
2.3.4 Rheumatoid Arthritis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rheumatoid Arthritis Testing by Players
3.1.1 Global Rheumatoid Arthritis Testing Revenue by Players (2019-2024)
3.1.2 Global Rheumatoid Arthritis Testing Revenue Market Share by Players (2019-2024)
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rheumatoid Arthritis Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Testing Revenue in 2023
3.5 Global Key Players of Rheumatoid Arthritis Testing Head office and Area Served
3.6 Global Key Players of Rheumatoid Arthritis Testing, Product and Application
3.7 Global Key Players of Rheumatoid Arthritis Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Testing Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Testing Historic Market Size by Type (2019-2024)
4.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2025-2030)
5 Rheumatoid Arthritis Testing Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2019-2024)
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rheumatoid Arthritis Testing Market Size (2019-2030)
6.2 North America Rheumatoid Arthritis Testing Market Size by Type
6.2.1 North America Rheumatoid Arthritis Testing Market Size by Type (2019-2024)
6.2.2 North America Rheumatoid Arthritis Testing Market Size by Type (2025-2030)
6.2.3 North America Rheumatoid Arthritis Testing Market Share by Type (2019-2030)
6.3 North America Rheumatoid Arthritis Testing Market Size by Application
6.3.1 North America Rheumatoid Arthritis Testing Market Size by Application (2019-2024)
6.3.2 North America Rheumatoid Arthritis Testing Market Size by Application (2025-2030)
6.3.3 North America Rheumatoid Arthritis Testing Market Share by Application (2019-2030)
6.4 North America Rheumatoid Arthritis Testing Market Size by Country
6.4.1 North America Rheumatoid Arthritis Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Rheumatoid Arthritis Testing Market Size by Country (2019-2024)
6.4.3 North America Rheumatoid Arthritis Testing Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Market Size (2019-2030)
7.2 Europe Rheumatoid Arthritis Testing Market Size by Type
7.2.1 Europe Rheumatoid Arthritis Testing Market Size by Type (2019-2024)
7.2.2 Europe Rheumatoid Arthritis Testing Market Size by Type (2025-2030)
7.2.3 Europe Rheumatoid Arthritis Testing Market Share by Type (2019-2030)
7.3 Europe Rheumatoid Arthritis Testing Market Size by Application
7.3.1 Europe Rheumatoid Arthritis Testing Market Size by Application (2019-2024)
7.3.2 Europe Rheumatoid Arthritis Testing Market Size by Application (2025-2030)
7.3.3 Europe Rheumatoid Arthritis Testing Market Share by Application (2019-2030)
7.4 Europe Rheumatoid Arthritis Testing Market Size by Country
7.4.1 Europe Rheumatoid Arthritis Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Rheumatoid Arthritis Testing Market Size by Country (2019-2024)
7.4.3 Europe Rheumatoid Arthritis Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rheumatoid Arthritis Testing Market Size (2019-2030)
8.2 China Rheumatoid Arthritis Testing Market Size by Type
8.2.1 China Rheumatoid Arthritis Testing Market Size by Type (2019-2024)
8.2.2 China Rheumatoid Arthritis Testing Market Size by Type (2025-2030)
8.2.3 China Rheumatoid Arthritis Testing Market Share by Type (2019-2030)
8.3 China Rheumatoid Arthritis Testing Market Size by Application
8.3.1 China Rheumatoid Arthritis Testing Market Size by Application (2019-2024)
8.3.2 China Rheumatoid Arthritis Testing Market Size by Application (2025-2030)
8.3.3 China Rheumatoid Arthritis Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rheumatoid Arthritis Testing Market Size (2019-2030)
9.2 Asia Rheumatoid Arthritis Testing Market Size by Type
9.2.1 Asia Rheumatoid Arthritis Testing Market Size by Type (2019-2024)
9.2.2 Asia Rheumatoid Arthritis Testing Market Size by Type (2025-2030)
9.2.3 Asia Rheumatoid Arthritis Testing Market Share by Type (2019-2030)
9.3 Asia Rheumatoid Arthritis Testing Market Size by Application
9.3.1 Asia Rheumatoid Arthritis Testing Market Size by Application (2019-2024)
9.3.2 Asia Rheumatoid Arthritis Testing Market Size by Application (2025-2030)
9.3.3 Asia Rheumatoid Arthritis Testing Market Share by Application (2019-2030)
9.4 Asia Rheumatoid Arthritis Testing Market Size by Region
9.4.1 Asia Rheumatoid Arthritis Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Rheumatoid Arthritis Testing Market Size by Region (2019-2024)
9.4.3 Asia Rheumatoid Arthritis Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Rheumatoid Arthritis Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Introduction
11.3.4 Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.3.5 Beckman Coulter Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Introduction
11.4.4 Siemens Healthineers Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.4.5 Siemens Healthineers Recent Developments
11.5 Augurex Life Sciences
11.5.1 Augurex Life Sciences Company Details
11.5.2 Augurex Life Sciences Business Overview
11.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Introduction
11.5.4 Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.5.5 Augurex Life Sciences Recent Developments
11.6 Svar Life Science AB
11.6.1 Svar Life Science AB Company Details
11.6.2 Svar Life Science AB Business Overview
11.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Introduction
11.6.4 Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.6.5 Svar Life Science AB Recent Developments
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Company Details
11.7.2 Aviva Systems Biology Business Overview
11.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Introduction
11.7.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.7.5 Aviva Systems Biology Recent Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Developments
11.10 Microdrop
11.10.1 Microdrop Company Details
11.10.2 Microdrop Business Overview
11.10.3 Microdrop Rheumatoid Arthritis Testing Introduction
11.10.4 Microdrop Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.10.5 Microdrop Recent Developments
11.11 Werfen
11.11.1 Werfen Company Details
11.11.2 Werfen Business Overview
11.11.3 Werfen Rheumatoid Arthritis Testing Introduction
11.11.4 Werfen Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.11.5 Werfen Recent Developments
11.12 Axis-Shield
11.12.1 Axis-Shield Company Details
11.12.2 Axis-Shield Business Overview
11.12.3 Axis-Shield Rheumatoid Arthritis Testing Introduction
11.12.4 Axis-Shield Revenue in Rheumatoid Arthritis Testing Business (2019-2024)
11.12.5 Axis-Shield Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Ìý
Ìý
*If Applicable.
